For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3a, 7ß-2-hydroxy-5ß-bile acid, UDCA) was first found in the bile of a black bear.
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
Scope of the Report:
Asia-Pacific is the largest consumption place, with a consumption market share nearly 47% in 2017. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of 26.6% in 2017.
The worldwide market for Ursodeoxycholic Acid is expected to grow at a CAGR of roughly 12.6% over the next five years, will reach 1040 million US$ in 2024, from 570 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Ursodeoxycholic Acid in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- ICE
- Mitsubishi Tanabe Pharma
- Daewoong Chemical
- PharmaZell GmbH
- Zhangshanbelling
- Dipharma Francis
- Grindeks
- Erregierre
- Abil Chempharma
- Biotavia Labs
- Suzhou Tianlu
- Arcelor Chemicals
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Synthetic UDCA
- Extraction UDCA
Market Segment by Applications, can be divided into
- Pharmacy
- Health Products
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ursodeoxycholic Acid product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ursodeoxycholic Acid, with price, sales, revenue and global market share of Ursodeoxycholic Acid in 2017 and 2018.
Chapter 3, the Ursodeoxycholic Acid competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ursodeoxycholic Acid breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Ursodeoxycholic Acid market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Ursodeoxycholic Acid sales channel, distributors, customers, research findings and conclusion, appendix and data source.